3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
11
Ovarian Neoplasms
5
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Radiation Pneumonitis
2
Peritoneal Neoplasms
2
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Inflammatory Breast Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Esophagogastric Adenocarcinoma
1
Endometrial Adenocarcinoma
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoid Tumor
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
nintedanib
×
Clear all
No trials found.